What Really Matters when Managing Pharmaceutical Projects
Pharmaceutical projects are becoming increasingly complex. This is a truism. But what does it actually mean for project execution?
Partnership with the customer with enthusiasm and motivation
From commissioning of the large-scale project to the signed handover protocol in just two and a half years: the project in Mexico for PiSA in cooperation with Excellence United partners was implemented in a remarkably short time and was very successful as well. What was the key to the success of the mega-project?
Phosphorus recovery on an industrial scale
Phosphate fertilizer from recycled sewage sludge ash: Glatt’s PHOS4green technology provides an economically and ecologically viable solution suitable for closing the phosphorus cycle.
Specialized Powder Synthesis
The composition and homogeneity of the raw materials used are becoming increasingly important in medical technology. With an advanced powder synthesis process, particularly high-quality nano- and microscale powders can be produced or refined – for example, for dental implants.
How to Tame Recalcitrant Ingredients with Technological Processes
Plant-based functional ingredients behave differently than manufacturers of nutraceuticals and cosmetic products would like. Innovative processes such as double microencapsulation can help them to overcome bioavailability and solubility challenges.
Service is More Than Just a Job
How good, agile service enhances a company’s reputation and becomes a gateway to the customer?Germany is not a service desert: For pharmaceutical machinery manufacturer Glatt, the after-sales service team is a source of pride.
Coating technology improvements deliver outstanding value for money
The coating process should produce smooth, uniform and taste-masked tablets, capsules, or pellets with a defined degree of solubility. In a manufacturing environment, these results need to be reproducible and the process time short.
HAPILA reaching completion of design for new GMP production plant for APIs
High-potency active ingredient specialist CDMO HAPILA GmbH (HAPILA) is ramping up its production capacity with two new GMP plants now in its manufacturing pipeline.
Fraunhofer IKTS operates world’s first flameless high-temperature powder synthesis plant
The German Fraunhofer Institute for Ceramic Technologies and Systems IKTS relies on technology from Glatt to produce high-purity, high-performance oxide materials.
Beyond the equipment – real solutions that add value
Tablets continue to be a popular pharmaceutical dosage form. They are relatively easy to manufacture, package and transport; offer good physical and chemical stability; and facilitate simple and accurate dosing.